Challenges in the management of a patient with Cowden syndrome: Case report and literature review

Hereditary Cancer in Clinical Practice

Volumn 10, Issue 1, 2012, Pages

  Melbarde Gorkuša, Inga ^a   Irmejs, Arvids ^a,b   Berziņa, Dace ^a   Štrumfa, Ilze ^a   Aboliņš, Arnis ^a   Gardovskis, Andris ^a   Subatniece, Signe ^a   Trofimovičs, Genadijs ^a   Gardovskis, Janis ^a   Miklaševičs, Edvins ^a  

^a RIGA STRADINS UNIVERSITY   (Latvia)

^b PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

Author keywords

Cancer; Cowden syndrome; PTEN; Risk reducing mastectomy

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; ARTICLE; ASPIRATION BIOPSY; BREAST DISEASE; BREAST FIBROADENOMA; BREAST LESION; BREAST RECONSTRUCTION; CANCER RISK; CASE REPORT; CAVERNOUS HEMANGIOMA; COWDEN SYNDROME; DNA ISOLATION; ECHOGRAPHY; ENDOMETRIUM CARCINOMA; FEMALE; GASTROSCOPY; GENE SEQUENCE; HIGH RISK PATIENT; HUMAN; HYSTERECTOMY; IMPLANT; IRON DEFICIENCY ANEMIA; LIVER HEMANGIOMA; MACROCEPHALY; MASTECTOMY; METRORRHAGIA; MISSENSE MUTATION; NODULAR GOITER; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYP; PREOPERATIVE EVALUATION; SALPINGOOOPHORECTOMY; THYROIDECTOMY;

EID: 84862131620     PISSN: 17312302     EISSN: 18974287     Source Type: Journal    
DOI: 10.1186/1897-4287-10-5     Document Type: Article

References (18)

1. Nelen MR, Kremer H, Konings IB, Schoute F, van Essen AJ, Koch R, Woods CG, Fryns JP, Hamel B, Hoefsloot LH, Peeters EA, Padberg GW. Novel PTEN mutations in patients with Cowden disease: absence of clear genotypephenotype correlations. Eur J Hum Genet 1999, 7:267-273. 10.1038/sj.ejhg.5200289, 10234502.
2. Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MM, Easton DF, Eeles RA, Hodgsen S, Mulvihill JJ, Murday VA, Tucker MA, Mariman EC, Starink TM, Ponder BA, Ropers HH, Kremer H, Longy M, Eng C. Localization of the gene for Cowden disease to 10q22-23. Nat Genet 1996, 13:114-116. 10.1038/ng0596-114, 8673088.
3. Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, Zheng Z, Liaw D, Caron S, Duboué B, Lin AY, Richardson AL, Bonnetblanc JM, Bressieux JM, Cabarrot-Moreau A, Chompret A, Demange L, Eeles RA, Yahanda AM, Fearon ER, Fricker JP, Gorlin RJ, Hodgson SV, Huson S, Lacombe D, Eng C, et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 1998, 7:507-515. 10.1093/hmg/7.3.507, 9467011.
4. Pilarski R. Cowden syndrome: a critical review of the clinical literature. J Genet Couns 2009, 18:13-27. 10.1007/s10897-008-9187-7, 18972196.
5. Riegert-Johnson DL, Gleeson FC, Roberts M, Tholen K, Youngborg L, Bullock M, Boardman LA. Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients. Hered Cancer Clin Pract 2010, 8:6. 10.1186/1897-4287-8-6, 2904729, 20565722.
6. Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 2012, 18:400-407. 10.1158/1078-0432.CCR-11-2283, 22252256.
7. Eng C. PTEN: one gene, many syndromes. Hum Mutat 2003, 22:183-198. 10.1002/humu.10257, 12938083.
8. Brownstein MH, Wolf M, Bikowski JB. Cowden's disease: a cutaneous marker of breast cancer. Cancer 1978, 41:2393-2398. 10.1002/1097-0142(197806)41:6<2393::AID-CNCR2820410644>3.0.CO;2-K, 657103.
9. Vasovčák P, Senkeříková M, Hatlová J, Křepelová A. Multiple primary malignancies and subtle mucocutaneous lesions associated with a novel PTEN gene mutation in a patient with Cowden syndrome: case report. BMC Med Genet 2011, 12:38. 3065398, 21406108.
10. Mutter GL, Lin MC, Fitzgerald JT, Kum JB, Baak JP, Lees JA, Weng LP, Eng C. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 2000, 92:924-391. 10.1093/jnci/92.11.924, 10841828.
11. Heald B, Mester J, Rybicki L, Orloff MS, Burke CA, Eng C. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology 2010, 139:1927-1933. 10.1053/j.gastro.2010.06.061, 20600018.
12. Schrager CA, Schneider D, Gruener AC, Tsou HC, Peacocke M. Clinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer. Hum Pathol 1998, 29:47-53. 10.1016/S0046-8177(98)90389-6, 9445133.
13. Pilarski R, Stephens JA, Noss R, Fisher JL, Prior TW. Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features. J Med Genet 2011, 48:505-512. 10.1136/jmg.2011.088807, 21659347.
14. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994, 343:692-695.
15. King MC, Marks JH, Mandell JB. New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003, 302:643-646. 10.1126/science.1088759, 14576434.
16. Hoover DJ, Paragi PR, Santoro E, Schafer S, Chamberlain RS. Prophylactic mastectomy in high risk patients: a practice-based review of the indications. Do we follow guidelines?. Breast Disease 2010, 31:19-27.
17. Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol 2004, 22:1055-1062. 10.1200/JCO.2004.04.188, 14981104.
18. Ali E, Athanasopoulos PG, Forouhi P, Malata CM. Cowden syndrome and reconstructive breast surgery: case reports and review of the literature. J Plast Reconstr Aesthet Surg 2011, 64:545-549. 10.1016/j.bjps.2010.04.047, 20627761.